Investing in biotech and therapeutics
Over the past year, some of the most interesting and intellectually-stimulating pitches we heard have come from startups in biotech, specifically companies developing therapeutics. From non-hormonal contraceptives that work for men and women to muscle-promoting gene therapy, the potential impact of these new drugs is both immeasurable and inspiring. So, it comes as no surprise […]
Building on top of EHRs
Traditionally, startups in healthcare have had challenges with distribution. This is not any different from companies in other industries, but innovation is not fully “permissionless” because of regulation, the many stakeholders involved (i.e. government, payers, hospitals/clinics, physicians, caregivers, and patients) with competing incentives, and the power of incumbents that continue to consolidate the market (i.e. […]
Expanding our bio/healthcare thesis
Our first investment in healthcare was five years ago in Figure 1, a platform for viewing and discussing real-world medical cases with healthcare professionals. This investment shaped our original thesis in the category. Figure 1 plays outside the healthcare care system; it’s permissionless innovation, like Yammer or Slack in the enterprise. As we wrote in our Digital […]
Our Approach to Investing in Genomics and Biosciences
It’s hard to believe that it has been a year and a half since we updated our healthcare thesis, as a follow-up to our blog series with Union Square Ventures on the future of healthcare. While we are still spending time on digital health, we have been focusing more on genomics and biosciences as a means to […]
Personalized medicine can’t come soon enough
I’m scheduling my fourth knee surgery. But Ange… how is that possible when you only have 2 knees? Many years of playing Ultimate Frisbee… As I’m heading into this surgery, it has occurred to me that personalized medicine cannot come soon enough. Below I’m going to share my own health story and struggles associated with […]